Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
There has been increasing interest in the role of glutamate in mood disorders, especially given the profound effect of the glutamate receptor antagonist ketamine in improving depressive symptoms in patients with treatment-resistant depression. One pathway by which glutamate alterations may occur in mood disorders involves inflammation. Increased inflammation has been observed in a significant subgroup of patients with mood disorders, and inflammatory cytokines have been shown to influence glutamate metabolism through effects on astrocytes and microglia. In addition, the administration of the inflammatory cytokine interferon-alpha has been shown to increase brain glutamate in the basal ganglia and dorsal anterior cingulate cortex as measured by magnetic resonance spectroscopy (MRS). Moreover, MRS studies in patients with major depressive disorder have revealed that increased markers of inflammation including C-reactive protein correlate with increased basal ganglia glutamate, which in turn was associated with anhedonia and psychomotor retardation. Finally, human and laboratory animal studies have shown that the response to glutamate antagonists such as ketamine is predicted by increased inflammatory cytokines. Taken together, these data make a strong case that inflammation may influence glutamate metabolism to alter behavior, leading to depressive symptoms including anhedonia and psychomotor slowing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation can impact almost all aspects of glutamate neurotransmission (See Haroon and Miller, 2017 for review).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Haroon and Miller, 2017
In the citing paper
“A recent study reported a 38% prevalence of metabolic syndrome in patients with TRD, and it has been estimated that approximately one-third of depressed patients have elevated inflammatory markers.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
In the citing paper
“It has been previously described that inflammation leads to glutamate excitotoxicity and synaptic destruction in depression.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
In the citing paper
“A recent study reported a 38% prevalence of metabolic syndrome in patients with TRD, and it has been estimated that approximately one-third of depressed patients have elevated inflammatory markers.189”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [189]
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Self-citationInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Self-citationAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884
Astrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1722 · Cited by 1,770
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Research works printed but not linked: 2
- CDC (2015) Suicide - facts at a glance 2015. Centers for Disease Control, Atlanta, GA, USA
- Hashemian F, Majd M, Hosseini SM, Sharifi A, Panahi MVS, Bigdeli O (2011) A randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in the treatment of a drug-naive women with major depression. Klinik Psikofarmakoloji Bulteni 21:S183–S184
Cited by
Items 101–165 of 165
Eid, R. S., Lieblich, S. E., Wong, S. J., & Galea, L. A. M. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100199 · Cited by 11
Guerrero, L. R., Hong, S., Tarraf, W., Perreira, K. M., Camacho, Á., Kohn, J. N., Jimenez, D. E., Talavera, G. A., Gallo, L. C., Allison, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289833 · Cited by 10
The Role of Vesicle Release and Synaptic Transmission in Depression
Zhang, C., Zhu, L., Shi, H., & Zhu, L. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.10.001 · Cited by 9
Mohammad, T. A. M., Mohammad, T. A. M., & Shawis, T. N. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111047 · Cited by 9
The development and tendency of depression researches: Viewed from the microbiota-gut-brain axis
Liang, S., Wu, X., Xu, H., Niu, Y., & Jin, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972017-01182 · Cited by 9
Interrelation of auto-immune process, endocrine disorders and depression
Mayorova, M. A., Петрова, Н. Н., Stroev, U. I., Churilov, L. P., & Shoenfeld, Y. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-1-8-19 · Cited by 9
Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression
Getachew, B., & Tizabi, Y. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112220 · Cited by 9
Physical Activity and Depression in Breast Cancer Patients: Mechanisms and Therapeutic Potential
Li, A., Zheng, X., Liu, D., Huang, R., Ge, H., Cheng, L. J., Zhang, M., & Cheng, H. (2025) · Current Oncology · doi:10.3390/curroncol32020077 · Cited by 8
Jamali, F., Mousavi, S., Rad, A. H., Meshkini, A., Alikhah, H., Houshyar, J., Moghadam, S. K., Yaghoubi, S. M., Asghari, K. M., Ilkhchi, M. T., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10513-6 · Cited by 8
Kuhlman, K. R., Irwin, M. R., Ganz, P. A., Cole, S. W., Manigault, A. W., Crespi, C. M., & Bower, J. E. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.019 · Cited by 8
The relationship between cannabis use and taurine: A MRS and metabolomics study
Newman, S. D., Martin, A. M. S., Raymond, D., Cheng, H., Wilson, L. S., Barnes, S., & O’Donnell, B. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269280 · Cited by 7
Anti-inflammatory Drugs in the Treatment of Depression
Cavanagh, J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_459 · Cited by 6
Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized Psychiatry
Murata, S., Oxenkrug, G. F., & Halaris, A. E. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16020118 · Cited by 6
Has the time come to treat depression with anti‐inflammatory medication?
Brundin, L., & Achtyes, E. D. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13031 · Cited by 6
Kakanakova, A., Popov, S. P., & Maes, M. H. J. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200228093935 · Cited by 6
From air to mind: unraveling the impact of indoor pollutants on psychiatric disorders
Torres, G., Subbaiah, R. T., Sood, R. A., & Leheste, J. R. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1511475 · Cited by 5
Loupy, K. M., Dawud, L. M., Zambrano, C. A., Lee, T., Heinze, J. D., Elsayed, A. I., Hassell, J. E., D'Angelo, H. M., Frank, M. G., Maier, S. F., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000544842 · Cited by 5
Valizadeh, P., Jannatdoust, P., Bagherieh, S., Cattarinussi, G., Squarcina, L., Maleki, S., Sambataro, F., Barone, Y., & Delvecchio, G. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119661 · Cited by 5
Kassar, O., Farag, N., Selim, A., Taman, L., Alaa, M., Elshahat, A., & Abouelmagd, M. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03845-1 · Cited by 5
Khan, A., Ronan, P. J., & Rahman, S. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-026-10279-w · Cited by 4
Imaging Metabotropic Glutamate Receptor 5 and Excitatory Neural Activity in Autism
Naples, A. J., Yang, Y., Gravel, P., Toyonaga, T., Sadabad, F. E., Koohsari, S., Pittman, B. P., Gallezot, J., Pisani, L., Finn, C., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20241084 · Cited by 4
Hertanto, A. C. H., Marchianti, A. C. N., & Hasan, M. (2023) · Amerta Nutrition · doi:10.20473/amnt.v7i2.2023.283-294 · Cited by 4
Circulating Cytokines Predict 1H-Proton MRS Cerebral Metabolites in Healthy Older Adults
Langer, K. G., Cohen, R. A., Porges, E. C., Williamson, J. B., & Woods, A. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690923 · Cited by 4
Sterrett, J. D., Andersen, N. D., & Lowry, C. A. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_10 · Cited by 4
Li, W., Xiao, R., Chen, X., Pu, J., Chen, J., Wang, H., Liu, L., Li, D., Zhang, Y., Li, W. Y., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70549 · Cited by 3
Zaongo, S. D., Harypursat, V., Rashid, F., Dahourou, D. L., Ouédraogo, A., & Chen, Y. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1261784 · Cited by 3
Feng, Z., Li, Y., Cai, Y., Yang, F., Zhou, X., Feng, M., & Li, W. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1608722 · Cited by 3
RetractedCarlson, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1644175 · Cited by 3
Circulating inflammatory markers predict depressive symptomatology in COVID-19 survivors
Palladini, M., Mazza, M. G., LORENZO, R. D., Spadini, S., Aggio, V., Bessi, M., Calesella, F., Bravi, B., Rovere, P. Q., & Benedetti, F. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156839 · Cited by 3
Lyons, S. J., Beck, I., & Depue, B. E. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121127 · Cited by 3
Study on serum metabolomics characteristics of obese patients with erectile dysfunction
Lin, Y. P., Pan, R., Deng, R., Fang, S., Yang, H., Zhang, X., & Cheng, W. (2024) · Medicine · doi:10.1097/md.0000000000040093 · Cited by 2
Abdallah, M. S., Mosalam, E. M., Hassan, A., Ramadan, A. N., Omara‐Reda, H., Zidan, A. A., Samman, W. A., & Elberri, E. I. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14010 · Cited by 2
RetractedApplication of Anesthetic Agents in Depression
Vutskits, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93273-8.00026-2 · Cited by 1
Zou, T., Mei, C., Liang, X., Shang, X., & Duan, G. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70043 · Cited by 1
Xie, J.-X., & Zhou, L.-W. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11357-7 · Cited by 1
Tang, G., Chen, G., Chen, P., Chen, F., Wang, J., Luo, Z., Qi, Z., Zhong, S., Yang, H., Zhong, H., et al. (2026) · Psychological Medicine · doi:10.1017/s0033291725100834 · Cited by 1
Ferraro, M. G., Stanley, A., Lippiello, P., Pascarella, S., Speranza, L., Ricci, M., Volpicelli, F., Chieffi, S., & Miniaci, M. C. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0085 · Cited by 1
Predictable Biomarkers for Rapid-Acting Antidepressant Response to Ketamine
Tan, Y., & Hashimoto, K. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_3 · Cited by 1
Трофимов, А. Н. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240205at · Cited by 1
Silva, A. R. C. E. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/3avq-xx35 · Cited by 1
Targeting Glutamate in Prostate Cancer-Induced Depression
Young, K. (2017) · MacSphere (McMaster University) · doi:10.71548/24670
de Sousa, A. S. P. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Draganov, M., Arranz, M. J., Vives‐Gilabert, Y., Jubero, M., de Diego-Adeliño, J., Àvila-Parcet, A., Puigdemont, D., & Portella, M. J. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111348
Ketamine for Treatment-Resistant Depression
Madhloom, R. S. (2021) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_15_21
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_10
Erkrankungen von Leber und Pankreas
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_7
Anisman, H., Hayley, S. P., & Kusnecov, A. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00006-5
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Khan, A., Ronan, P. J., & Rahman, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5229259
The new normal: neural network adaptations in late-life depression
Haroon, E., & Miller, A. H. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02145-9
Self-citationSilva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P., Silva, M. L., & Padrão, P. (2021) · Figshare · doi:10.6084/m9.figshare.14190359
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P., Silva, M. L., & Padrão, P. (2021) · Figshare · doi:10.6084/m9.figshare.14190365
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P., Silva, M. L., & Padrão, P. (2021) · Figshare · doi:10.6084/m9.figshare.14190362
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P., Silva, M. L., & Padrão, P. (2021) · Figshare · doi:10.6084/m9.figshare.14190356
de Sousa, A. S. P. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Genetic evidence for repurposing immunomodulatory drugs for major depressive disorderPreprint
Jesuthasan, J., ter Kuile, A., Roiser, J. P., Carvalho, L. A., Pitman, A., Chopade, S., Finan, C., Schmidt, A. F., & Pingault, J. (2026) · medRxiv · doi:10.64898/2026.02.07.26345798
Cefepime Alleviates Comorbid Pain and Depression Induced by Lipopolysaccharide in Female Mice
Khan, A., Ronan, P. J., & Rahman, S. (2026) · Brain Sciences · doi:10.3390/brainsci16030306
Progress on the neurotrophic effects of antidepressant drugs
Jing, P., Liu, X.-C., Xiao-peng, Y. I. N., Fu, Y., Tian, Q., & (673328), X.-B. Z. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i4.115300
Understanding the Link Between Environmental Pollutants, Brain & Behavior
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7781-3
Yamamuro, K., Yamauchi, T., & Makinodan, M. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1915506
Zhang, B., & Li, C. (2026) · Depression and Anxiety · doi:10.1155/da/1891046
Brás, J. P., Pinto, S., von Doellinger, O., Prata, J., Coelho, R., Barbosa, M. A., Almeida, M. I., & Santos, S. G. (2023) · doi:10.3389/fpsyt.2023.1227618.s001
Silva, A. R., Bernardo, A., de Mesquita, M. F., Vaz-Patto, J., Moreira, P., Silva, M. L., & Padrão, P. (2022) · doi:10.3389/fnut.2022.856216.s001
Metadata
- Authors
- Haroon, E., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H.
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 31
- Pages
- 173-198
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W2552532188
- Cited by
- 153
- References
- 137
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 18 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 5 · 2016: 2
- FWCI
- 2.77
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Mental Health (R21MH077172, R01MH112076, R03MH100273, R01MH107033, R01MH087604, K23MH091254, R21MH105897)
- National Cancer Institute (P30CA138292)
- National Center for Research Resources (UL1RR025008)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- brain glutamate, inflammation, depression, major depressive disorder, inflammatory cytokines, ketamine, treatment-resistant depression, astrocytes, microglia, interferon-alpha, C-reactive protein, basal ganglia, dorsal anterior cingulate cortex, anhedonia, psychomotor retardation, glutamate metabolism
- MeSH terms
- Animals, Depression, Humans, Inflammation, Excitatory Amino Acid Antagonists, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.